News
Poxel receives orphan drug designation from European Commission for PXL770 and PXL065 for treatment...
The European Commission has granted orphan drug designation (ODD) for Poxel's PXL770 and PXL065 for the treatment of adrenoleukodystrophy (ALD).
The decision follows a positive...
Alvotech and Bioventure’s AVT02 approved in Saudi Arabia
The Saudi Food & Drug Authority (SFDA) has approved the manufacturing and distribution of Alvotech and Bioventure's AVT02, a biosimilar for Humira (adalimumab), which is...
New £1.6m research project to use AI to tackle antibiotic resistant infections
A researcher at the University of Nottingham has been awarded £1.6 million to look at how artificial intelligence (AI) could help us to tackle...
